Gut is the journal of the British Society of Gastroenterology and is published by the BMJ Group.
Congratulations to our researchers qworking on identifying new therapetuic targets for chronic liver disease for the article they have just published in the prestigious journal Gut, which has an impact factor of 17.943.
The article higlights how Rilvipirine, an antiretroviral drug, induces an effect that protects against hepatic fibrosis, representing a strategy to treat this serious condition, and which coud lead the the indetificaton of new therapetuic targets.